BioSerenity Investors

35 investors on Angel Roster list BioSerenity in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Early Stage Venture and the largest groups are based in France, Italy and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name BioSerenity can appear together.

Investors listed
35
With verified email
26%
Most common stage
Early Stage Venture
Top location
France

Updated October 13, 2026 · How we compile this data

Top 35 BioSerenity investors

The most complete profiles first. Showing 35 of 35.

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Valery HuotVerified

    Venture Capital, Private Equity Firm · France

    Early Stage VentureHealth CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Bao DinhVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Christophe SimonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Eric GallerneVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Luc MaruendaVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Matthieu BaretVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas DebockVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas NedelecVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Robin RivatonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Annette Fainbloom

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Arthur Balland

    Venture Capital, Private Equity Firm · France

    Early Stage VentureHealth CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Emmanuel Fiorentino

    Venture Capital, Private Equity Firm · France

    Early Stage VentureHealth CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Franck Noiret

    Venture Capital, Private Equity Firm · France

    Early Stage VentureHealth CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Jacques Franchi

    Venture Capital, Private Equity Firm · France

    Early Stage VentureHealth CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Matthieu B.

    Venture Capital, Private Equity Firm, Investor · France

    SeedPre-SeedHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Nicolas de Loiray

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Pietro Zerauschek

    Venture Capital, Private Equity Firm · Italy

    Early Stage VentureHealth CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Simon Couturier

    Venture Capital, Private Equity Firm · France

    Early Stage VentureHealth CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Chiara Venezia

    Private Equity Firm · Italy

    Health CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Daniel Emersleben

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Florian Zimmermann

    Private Equity Firm · Germany

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Giulio Farinelli

    Private Equity Firm · Italy

    Health CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Jean

    Private Equity Firm · France

    Health CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Jean Plamondon

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Marie

    Private Equity Firm · France

    Health CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Nicolas Chaudron

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Nicolas Manardo

    Private Equity Firm · France

    Health CareWearablesGeneticsWellness

    Portfolio: FeetMe, BIOMODEX, Labeyrie Fine Foods, Colonies and 6 more

    Contact details available

  • Peter Neubeck

    Venture Capital, Private Equity Firm · Germany

    Health CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Thierry Legeais

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

Frequently asked questions

How many BioSerenity investors are on Angel Roster?

Angel Roster lists 35 BioSerenity investors. 9 of them (26%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (33) and Venture Capital Firms (17). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do BioSerenity investors invest in?

Among those that list a stage, the most common are Early Stage Venture (7), Seed (7) and Series B (2).

Where are BioSerenity investors based?

Most are based in France (29), Italy (3) and Germany (2).

Which companies have BioSerenity investors backed?

The most-backed portfolio companies among them are FeetMe (35), Stilla Technologies (35), Colonies (28), Ermium Therapeutics (23) and Corlieve Therapeutics (23).

How do I contact BioSerenity investors?

Create a free Angel Roster account to search and filter all 35, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.